Sartorius Aktiengesellschaft - Asset Resilience Ratio
Sartorius Aktiengesellschaft (SRT3) has an Asset Resilience Ratio of 4.48% as of September 2025. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. Read SRT3 current and long-term liabilities for a breakdown of total debt and financial obligations.
Liquid Assets
Total Assets
Resilience Assessment
Asset Resilience Ratio Trend (2008–2024)
This chart shows how Sartorius Aktiengesellschaft's Asset Resilience Ratio has changed over time. See net assets of Sartorius Aktiengesellschaft for net asset value and shareholders' equity analysis.
Liquid Assets Composition Over Time
This chart breaks down Sartorius Aktiengesellschaft's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For market capitalisation and broader financial context, see Sartorius Aktiengesellschaft (SRT3) total market value.
Current Liquid Assets Breakdown
| Component | Amount | % of Total Assets |
|---|---|---|
| Cash & Equivalents | €389.90 Million | 4.06% |
| Short-term Investments | €40.70 Million | 0.42% |
| Total Liquid Assets | €430.60 Million | 4.48% |
Asset Resilience Insights
- Limited Liquidity: Sartorius Aktiengesellschaft maintains only 4.48% of assets in liquid form.
- This low level may indicate efficient asset utilization but could pose risks during economic downturns.
- The company primarily holds liquidity in cash and equivalents rather than short-term investments.
Sartorius Aktiengesellschaft Industry Peers by Asset Resilience Ratio
Compare Sartorius Aktiengesellschaft's asset resilience ratio with other companies in the same industry.
| Company | Industry | Asset Resilience Ratio |
|---|---|---|
|
Alcon AG
SW:ALC |
Medical Instruments & Supplies | 0.26% |
|
iRay Technology Co Ltd
SHG:688301 |
Medical Instruments & Supplies | 0.68% |
|
Anbio Biotechnology Class A Ordinary Shares
NASDAQ:NNNN |
Medical Instruments & Supplies | 29.19% |
|
Jiangsu Nanfang Medical
SHG:603880 |
Medical Instruments & Supplies | 2.27% |
|
SDI Ltd
AU:SDI |
Medical Instruments & Supplies | 6.36% |
|
I.Ceram SA
PA:ALICR |
Medical Instruments & Supplies | -1.61% |
|
Ansell Ltd
AU:ANN |
Medical Instruments & Supplies | 4.42% |
|
Nanosonics Ltd
AU:NAN |
Medical Instruments & Supplies | 51.82% |
Annual Asset Resilience Ratio for Sartorius Aktiengesellschaft (2008–2024)
The table below shows the annual Asset Resilience Ratio data for Sartorius Aktiengesellschaft.
| Year | Asset Resilience Ratio (%) | Liquid Assets | Total Assets | Change |
|---|---|---|---|---|
| 2024-12-31 | 8.20% | €828.70 Million ≈ $968.84 Million |
€10.10 Billion ≈ $11.81 Billion |
+4.16pp |
| 2023-12-31 | 4.04% | €394.20 Million ≈ $460.86 Million |
€9.76 Billion ≈ $11.40 Billion |
+1.22pp |
| 2022-12-31 | 2.82% | €196.80 Million ≈ $230.08 Million |
€6.98 Billion ≈ $8.16 Billion |
-3.51pp |
| 2021-12-31 | 6.34% | €360.99 Million ≈ $422.03 Million |
€5.70 Billion ≈ $6.66 Billion |
+1.70pp |
| 2020-12-31 | 4.63% | €217.65 Million ≈ $254.45 Million |
€4.70 Billion ≈ $5.49 Billion |
+2.30pp |
| 2019-12-31 | 2.33% | €66.40 Million ≈ $77.63 Million |
€2.84 Billion ≈ $3.33 Billion |
-0.33pp |
| 2018-12-31 | 2.67% | €67.34 Million ≈ $78.73 Million |
€2.53 Billion ≈ $2.95 Billion |
-0.59pp |
| 2017-12-31 | 3.25% | €74.68 Million ≈ $87.31 Million |
€2.30 Billion ≈ $2.69 Billion |
-0.86pp |
| 2016-12-31 | 4.11% | €72.07 Million ≈ $84.25 Million |
€1.75 Billion ≈ $2.05 Billion |
+3.54pp |
| 2015-12-31 | 0.58% | €8.28 Million ≈ $9.68 Million |
€1.44 Billion ≈ $1.68 Billion |
-0.34pp |
| 2014-12-31 | 0.91% | €11.63 Million ≈ $13.60 Million |
€1.27 Billion ≈ $1.49 Billion |
-0.07pp |
| 2013-12-31 | 0.98% | €11.54 Million ≈ $13.49 Million |
€1.17 Billion ≈ $1.37 Billion |
+1.09pp |
| 2012-12-31 | -0.11% | €-1.17 Million ≈ $-1.36 Million |
€1.07 Billion ≈ $1.25 Billion |
-0.02pp |
| 2011-12-31 | -0.08% | €-819.00K ≈ $-957.50K |
€963.84 Million ≈ $1.13 Billion |
+0.31pp |
| 2008-12-31 | -0.40% | €-3.45 Million ≈ $-4.04 Million |
€865.00 Million ≈ $1.01 Billion |
-- |
About Sartorius Aktiengesellschaft
Sartorius Aktiengesellschaft provides bioprocess solutions, and lab products and services worldwide. The company offers multi-parallel, benchtop, single-use, stainless steel, cell culture, rocking motion, and microbial bioreactors; software apps for bioreactors and cell culture shake flasks; fermenters; cell culture media, biolayer interferometry, microbiological testing, and fluid management pro… Read more